Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Allende

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
The International Journal of Biological Markers|April 1, 1996
CYFRA 21.1 cytosolic levels in breast diseases. Correlation with other clinical and biological parametersA Ruibal, B Fernández Llana, A Alba, et al.
The International Journal of Biological Markers|July 1, 1991
Different immunoreactivity between cyst fluid and serum prolactin in women with cystic breast diseaseM T Allende, F Vizoso, E Mosquera, et al.
Bulletin Du Cancer|January 1, 1991
BCM-IMx behaviour in patients with lung diseasesM T Allende, J Hernández, M Fernández Fernández, et al.
The International Journal of Biological Markers|July 1, 1996
Preoperative CEA and TAG-72 serum levels as prognostic indicators in resectable gastric carcinomaA González, F Vizoso, M T Allende, et al.
The International Journal of Biological Markers|October 1, 1991
Serum BCM-IMx levels in 376 patients with non-malignant diseasesM T Allende, M Fernández Fernández, B Fernández Llana, et al.
Revista Espanola De Fisiologia|December 1, 1989
[Hyperaluminemia and parathormone release]M J Virgós, B Díaz, M T Allende, et al.
The International Journal of Biological Markers|October 1, 1993
Placental serum alkaline phosphatase, defined by monoclonal antibody C2, in non-malignant diseases and in non-germinal tumorsB Fernández Llana, M Fernández Fernández, P Fernández Raigoso, et al.
The International Journal of Biological Markers|October 1, 1994
Cytosolic tissue-type plasminogen activator (t-PA) levels in breast tumors and hormone dependence. Role of pS2A Ruibal, A Alvarez, B Fernández Llana, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Zn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parametersI Díez-Itza, L M Sánchez, M T Allende, et al.
The International Journal of Biological Markers|November 24, 1999
The pS2 protein in primary colorectal carcinomas and in surrounding mucosaA Junco, J C Rodríguez, M T Allende, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
The International Journal of Biological Markers|April 1, 1996
CYFRA 21.1 cytosolic levels in breast diseases. Correlation with other clinical and biological parametersA Ruibal, B Fernández Llana, A Alba, et al.
The International Journal of Biological Markers|July 1, 1991
Different immunoreactivity between cyst fluid and serum prolactin in women with cystic breast diseaseM T Allende, F Vizoso, E Mosquera, et al.
Bulletin Du Cancer|January 1, 1991
BCM-IMx behaviour in patients with lung diseasesM T Allende, J Hernández, M Fernández Fernández, et al.
The International Journal of Biological Markers|July 1, 1996
Preoperative CEA and TAG-72 serum levels as prognostic indicators in resectable gastric carcinomaA González, F Vizoso, M T Allende, et al.
The International Journal of Biological Markers|October 1, 1991
Serum BCM-IMx levels in 376 patients with non-malignant diseasesM T Allende, M Fernández Fernández, B Fernández Llana, et al.
Revista Espanola De Fisiologia|December 1, 1989
[Hyperaluminemia and parathormone release]M J Virgós, B Díaz, M T Allende, et al.
The International Journal of Biological Markers|October 1, 1993
Placental serum alkaline phosphatase, defined by monoclonal antibody C2, in non-malignant diseases and in non-germinal tumorsB Fernández Llana, M Fernández Fernández, P Fernández Raigoso, et al.
The International Journal of Biological Markers|October 1, 1994
Cytosolic tissue-type plasminogen activator (t-PA) levels in breast tumors and hormone dependence. Role of pS2A Ruibal, A Alvarez, B Fernández Llana, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Zn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parametersI Díez-Itza, L M Sánchez, M T Allende, et al.
The International Journal of Biological Markers|November 24, 1999
The pS2 protein in primary colorectal carcinomas and in surrounding mucosaA Junco, J C Rodríguez, M T Allende, et al.
Pageof 8